Vivek Bhalla, MD, FASN, FAHA
banner
bhallaresearch.bsky.social
Vivek Bhalla, MD, FASN, FAHA
@bhallaresearch.bsky.social
Exploring Molecular Mechanisms of Kidney Disease and Hypertension; Associate Professor, Stanford Medicine; Director, Stanford Hypertension Center; Director, Stanford Pre Renal Initiative; former Chair, Council on Kidney and Cardiovascular Disease, AHA
Reposted by Vivek Bhalla, MD, FASN, FAHA
Urine microalbumin getting Super Bowl star treatment with Sofia Vergara and Octavia Spencer.
February 9, 2026 at 1:37 AM
I would simply like to add my name to the chorus of folks who are struggling with this new NIH biosketch format. As both a grant writer to the NIH and a grant reviewer for the NIH, I have tried to see potential merits of this, but 1/2
January 25, 2026 at 6:28 AM
Reposted by Vivek Bhalla, MD, FASN, FAHA
We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 .
med.stanford.edu/hypertension/e…

-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
https://med.stanford.edu/hypertension/e…
September 25, 2025 at 8:02 AM
Reposted by Vivek Bhalla, MD, FASN, FAHA
Ahead of #KidneyWk25, we are recruiting a hypertension fellow to the Stanford Hypertension Center for July 2026. Please come find me at ASN.

med.stanford.edu/nephrology/e...
Hypertension Fellowship
med.stanford.edu
November 5, 2025 at 7:57 AM
Ahead of #KidneyWk25, we are recruiting a hypertension fellow to the Stanford Hypertension Center for July 2026. Please come find me at ASN.

med.stanford.edu/nephrology/e...
Hypertension Fellowship
med.stanford.edu
November 5, 2025 at 7:57 AM
We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 .
med.stanford.edu/hypertension/e…

-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
https://med.stanford.edu/hypertension/e…
September 25, 2025 at 8:02 AM
x.com
September 25, 2025 at 8:02 AM
Reposted by Vivek Bhalla, MD, FASN, FAHA
A famous nephrologist getting ready to go see the most famous guy who plays a nephrologist @glaucomflecken.bsky.social @stanforddeptmed.bsky.social Grand Rounds!
September 5, 2025 at 4:27 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
#ENDO2026 Welcomes Your Ideas | Our annual meeting will take place in Chicago, IL, June 13–16, and I’m inviting YOU to shape the program💡Submit your symposium proposal or session suggestion by Tuesday, September 2: bit.ly/4flCMjl
#endocrinology @TheEndoSociety
ENDO 2026 Session Submissions
ENDO wouldn’t be possible without the insight and expertise of the Endocrine community. Your ideas are essential to building a dynamic, forward-thinking program that reflects the full breadth of our f...
bit.ly
August 28, 2025 at 4:35 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
Motherfucking wind farms…
July 30, 2025 at 5:02 PM
Dr. Alessia Fornoni @alessiafornoni.bsky.social University of Miami describing her journey as a physician scientist, mentor, and drug developer- from a small town in northern Italy to her many roles today
July 24, 2025 at 1:34 PM
Drs. Prabir Roy-Chaudry @asnkidney.bsky.social president of the ASN, @uncchapelhill.bsky.social as well as Drs. Rasheed Gbadegesin @dukepress.bsky.social and Emmanuel Opara @wakeforest.bsky.social kicking off the KUH R25 symposium @dknet.org at UNC chapel hill today
July 24, 2025 at 1:29 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
“There is a lot of pressure to essentially leave the country or not pursue research.” scim.ag/3Gz4VWW
‘It’s a nightmare.’ U.S. funding cuts threaten academic science jobs at all levels
“There is a lot of pressure to essentially leave the country or not pursue research,” one Ph.D. student says
scim.ag
July 8, 2025 at 1:13 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
Presented at the #ADASciSessions:

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. This phase 1–2 study supports the hypothesis that zimislecel can restore physiologic islet function and thus treat persons with type 1 diabetes. Full study results: nej.md/3ZGupbv
Stem Cell–Derived, Fully Differentiated Islets for Type 1 Diabetes | NEJM
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimisle...
nej.md
June 21, 2025 at 2:53 AM
Reposted by Vivek Bhalla, MD, FASN, FAHA
Congratulations to the #StanDOM recipients of the 2025 Stanford Medicine Awards, who were recognized for their outstanding contributions to medical education & leadership during the June 14 @stanfordmedicine.bsky.social graduation.
June 16, 2025 at 3:57 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
Atul Butte died yesterday.
The world lost a giant.
A big bear of a man.
With a huge smile.
With love for everyone.
With energy that could power a room.
I loved everything about Atul.
I loved how he was always happy.
I loved how excited he was about science and helping people.
June 14, 2025 at 6:35 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
I don't care if these monstrous ICE raids are a "federal operation". This is authoritarian violence, plain and simple.
June 8, 2025 at 8:28 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
June 3, 2025 at 7:13 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
Congratulations to all who advocated and thank you to all those who supported!!
🎉🎉🎉🎉🎉
@WHO.int
@ISN.org
#Guatamala

@CharuMalik.bsky.social
Ifeoma Ulasi
Magda Machalska

@UKKidney.org
@kidneycareuk.org
@KidneyResearch.org

#kidneyhealthforall
#WHA78
🌍 History made! For the first time, kidney care is on the global health agenda. #WHA78 adopted a landmark resolution recognizing kidney health in the fight against #NCDs.

👏 Thanks to Guatemala and the global kidney community for making this possible!

#KidneyHealthMatters
May 23, 2025 at 5:45 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
The Dutch are responsible for many wonderful things, but are any as great as the stroopwafel and coffee combo? 🇳🇱☕️🧇

Zosia is very jealous
May 4, 2025 at 11:03 AM
Reposted by Vivek Bhalla, MD, FASN, FAHA
In the Advance-HTN phase 2b trial of the aldosterone synthase inhibitor lorundrostat in participants with uncontrolled hypertension, lorundrostat was associated with greater reductions in blood pressure than placebo. Full trial results: nej.md/4ipbCIf

#MedSky #CardioSky
April 23, 2025 at 9:12 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
Kidney disease should be recognised on WHO's priority list of non-communicable diseases, alongside cancer, cardiovascular disease, and diabetes

https://go.nature.com/4lLJ5iY
Kidney disease is a worldwide killer. Treat it that way
The international community has a golden opportunity to start reining in the escalating, mostly ignored global burden of chronic kidney disease.
go.nature.com
April 22, 2025 at 4:26 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
The ASIs have arrived

www.nejm.org/doi/full/10....

Aldosterone synthase inhibitors - first one to finish the phase 3 line

#Lorundrostat #Hypertension
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension | NEJM
Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. In this mult...
www.nejm.org
April 23, 2025 at 10:01 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
Aaand it’s official, we have a new antihypertensive class!!!! 🎉🍾🎊

I like this RCT design in particular because it was open to both uncontrolled not-yet-resistant AND resistant hypertensive patients, opening to door to prescribe it as an earlier line agent

www.nejm.org/doi/full/10....
Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension | NEJM
Aldosterone dysregulation contributes to hypertension. Lorundrostat is an aldosterone synthase inhibitor, but data on its efficacy and safety in patients with hypertension are limited. In this mult...
www.nejm.org
April 23, 2025 at 10:38 PM
Reposted by Vivek Bhalla, MD, FASN, FAHA
The Women's Health Initiative is one of the most impactful studies in US history. It's been ongoing since the '90s, continually providing new insights, and NIH is cutting funding. Regional Centers are being closed. The Clinical Coordinating Center is now in limbo. For what? Utterly asinine... 🤬
April 22, 2025 at 1:48 AM